Jäger, Ulrich <br/><br/>
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.  [electronic resource] 

 -  Haematologica  Sep 2012 
 - 1431-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.2011.059246  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--blood<br/>Bone Marrow--drug effects<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphoma, Follicular--drug therapy<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Neoplasm Recurrence, Local--drug therapy<br/>Pilot Projects<br/>Prognosis<br/>Prospective Studies<br/>Remission Induction<br/>Rituximab<br/>Sex Factors<br/>Survival Rate<br/>Tissue Distribution<br/>Vidarabine--administration & dosage